Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Major alterations in the composition of the cartilage extracellular matrix occur in joint disease, such as osteoarthrosis. Additionally we are shipping Cartilage Intermediate Layer Protein, Nucleotide Pyrophosphohydrolase Antibodies (44) and Cartilage Intermediate Layer Protein, Nucleotide Pyrophosphohydrolase Kits (7) and many more products for this protein.
Showing 7 out of 7 products:
CILP rs2073711 TT is associated with increased risk of symmetrical hand osteoarthritis particularly in individuals with low variation in work tasks.
Meta-analysis. Our results confirm the positive association between CILP and intervertebral disc degeneration, providing novel clues for clarifying the role of CILP in the development of IVD (show IVD Proteins).
CILP is involved in the etiology of intervertebral disc degeneration among young adults.
The researchers found that the single nucleotide polymorphism (1184T/C) of the CILP gene is associated an increased risk of lumbar disc degeneration in male athletes.
CILP regulates TGF-beta (show TGFB1 Proteins) signaling and that this regulation has a crucial role in the etiology and pathogenesis of LDD.
These observations, together with the finding that CILP protein binds and inhibits TGF-beta1 (show TGFB1 Proteins), suggest that CILP and TGF-beta1 (show TGFB1 Proteins) may form a functional feedback loop that controls chondrocyte metabolism.
SNP analysis suggested that the CILP gene is not a major risk factor for symptoms of lumbar disc disease in Finnish or Chinese populations.
the CILP gene 1184T/C polymorphism is a significant risk factor for lumbar disc degeneration occurrence in Japanese collegiate judo athletes
Overexpression of CILP in the nucleus pulposus cells promotes disc degeneration, indicating that CILP plays a direct role in the pathogenesis of lumbar disc disease.
Major alterations in the composition of the cartilage extracellular matrix occur in joint disease, such as osteoarthrosis. This gene encodes the cartilage intermediate layer protein (CILP), which increases in early osteoarthrosis cartilage. The encoded protein was thought to encode a protein precursor for two different proteins\; an N-terminal CILP and a C-terminal homolog of NTPPHase, however, later studies identified no nucleotide pyrophosphatase phosphodiesterase (NPP) activity. The full-length and the N-terminal domain of this protein was shown to function as an IGF-1 antagonist. An allelic variant of this gene has been associated with lumbar disc disease.
cartilage intermediate layer protein 1
, cartilage intermediate layer protein 1 C1
, cartilage intermediate layer protein 1 C2
, cartilage intermediate-layer protein
, nucleotide pyrophosphohydrolase
, cartilage intermediate layer protein, nucleotide pyrophosphohydrolase
, cartilage intermediate layer protein 1-like
, CILP protein